JPRN-UMIN000018971已完成未知
The combination therapy of PEG-IFN alpha 2b, Ribavirin and Telaprevir for the patients with chronic hepatitis C:the study for treatment duration by response guided therapy and prediction of efficacy by gene analysis in Japan. - The response guided therapy of PEG-IFN alpha 2b, Ribavirin and Telaprevir for the patients with chronic hepatitis C
agoya university0 个研究点目标入组 500 人开始时间: 2015年10月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patients contraindication for telaprevir 2)patients with rush by telaprevir 3)patients who used contraindication drugs with telaprevir 4)pregnacy 5)pregnacy for partener 6)partner can not understand contraception 7)allergy for RBV 8)sevre heart disease 9)salasemia 10)sevre renal disease 11)mental desease 12)sevre liver disease 13)AIH 14)contraindication for PEG-IFN-2b 15)allergy for vaccine 16)shosaikoto user 17)plick test positive 18) a.Hb>12g/dl b. nuet>1,500/mm3 c.platetlet>100,000/mm3 19)past use of telaprevir 20)active infecious desisease 21)cancer 22)contraindication by doctor in charge
研究者
相似试验
已完成
不适用
Peg-IFN-alfa-2b/Ribavirin combination therapy for chronic hepatitis C patients: Effectiveness prediction by gene analysis and efficacy with Fluvastatin combinatiochronic hepatitis CJPRN-UMIN000008196Kanazawa University200
已完成
不适用
Efficasy of combination therapy PEG-IFN-alpha-2b and Ribavirin for patients with Serogroup1 and high titer HCV.Hepatitis CJPRN-C000000197Osaka university graduate school of medicine500
已完成
不适用
PEG-IFN-alfa2b/Ribavirin combination therapy for chronic hepatitis C patients with low platelet count: efficacy and safetychronic hepatitis CJPRN-UMIN000002377Kanazawa university100
已完成
不适用
Peg-IFN-alfa2a/Ribavirin combination therapy for chronic hepatitis C with serogroup1 and high viral load: analysis of IL28B gene and efficacy of vitamin D combinatiochronic hepatitis CJPRN-UMIN000008197Kanazawa university200
招募中
不适用
Effectiveness of PEG-IFN alfa-2b + Ribavirin combination therapy in patients with chronic hepatitis C after partial splenic embolization(PSE) or splenectomyChronic Hepatitis CJPRN-UMIN000001735Tokushima Municipal Hospital20